495 related articles for article (PubMed ID: 26194538)
21. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease.
Palikhe NS; Kim SH; Cho BY; Ye YM; Choi GS; Park HS
Allergy; 2010 Mar; 65(3):338-46. PubMed ID: 19796209
[TBL] [Abstract][Full Text] [Related]
22. A highly sensitive and specific genetic marker to diagnose aspirin-exacerbated respiratory disease using a genome-wide association study.
Shin SW; Park J; Kim YJ; Uh ST; Choi BW; Kim MK; Choi IS; Park BL; Shin H; Park CS
DNA Cell Biol; 2012 Nov; 31(11):1604-9. PubMed ID: 22994212
[TBL] [Abstract][Full Text] [Related]
23. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease.
Cardet JC; White AA; Barrett NA; Feldweg AM; Wickner PG; Savage J; Bhattacharyya N; Laidlaw TM
J Allergy Clin Immunol Pract; 2014; 2(2):208-13.. PubMed ID: 24607050
[TBL] [Abstract][Full Text] [Related]
24. Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD.
Shin S; Park JS; Kim YJ; Oh T; An S; Park CS
Mol Genet Genomics; 2012 May; 287(5):361-71. PubMed ID: 22457146
[TBL] [Abstract][Full Text] [Related]
25. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.
Eastman JJ; Cavagnero KJ; Deconde AS; Kim AS; Karta MR; Broide DH; Zuraw BL; White AA; Christiansen SC; Doherty TA
J Allergy Clin Immunol; 2017 Jul; 140(1):101-108.e3. PubMed ID: 28279492
[TBL] [Abstract][Full Text] [Related]
26. Leukotriene D
Liu T; Barrett NA; Nagai J; Lai J; Feng C; Boyce JA
J Allergy Clin Immunol; 2021 Jul; 148(1):195-208.e5. PubMed ID: 33285161
[TBL] [Abstract][Full Text] [Related]
27. Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease.
Ban GY; Cho K; Kim SH; Yoon MK; Kim JH; Lee HY; Shin YS; Ye YM; Cho JY; Park HS
Clin Exp Allergy; 2017 Jan; 47(1):37-47. PubMed ID: 27533637
[TBL] [Abstract][Full Text] [Related]
28. Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients.
Chandler AB; Earhart AD; Speich HE; Kueter TJ; Hansen J; White MM; Jennings LK
Thromb Res; 2010 Jan; 125(1):44-52. PubMed ID: 19487018
[TBL] [Abstract][Full Text] [Related]
29. Upper airways in aspirin-exacerbated respiratory disease.
Choi JH; Kim JH; Park HS
Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326
[TBL] [Abstract][Full Text] [Related]
30. Association of interleukin-25 levels with development of aspirin induced respiratory diseases.
Lee JU; Chang HS; Lee HJ; Bae DJ; Son JH; Park JS; Choi JS; Hwang HG; Park CS
Respir Med; 2017 Feb; 123():71-78. PubMed ID: 28137499
[TBL] [Abstract][Full Text] [Related]
31. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Kamide Y; Nakamura Y; Hamada Y; Tomita Y; Sekiya K; Tsuburai T; Izuhara K; Wakahara K; Hashimoto N; Hasegawa Y; Taniguchi M
Am J Respir Crit Care Med; 2020 Jun; 201(12):1488-1498. PubMed ID: 32142372
[No Abstract] [Full Text] [Related]
32. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
[TBL] [Abstract][Full Text] [Related]
33. Aspirin-Exacerbated Respiratory Disease.
Walgama ES; Hwang PH
Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
[TBL] [Abstract][Full Text] [Related]
34. Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease.
Jerschow E; Ren Z; Hudes G; Sanak M; Morales E; Schuster V; Spivack SD; Rosenstreich D
Ann Allergy Asthma Immunol; 2016 Apr; 116(4):321-328.e1. PubMed ID: 26822279
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E
Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
[TBL] [Abstract][Full Text] [Related]
36. Association analysis of formyl peptide receptor 2 (FPR2) polymorphisms and aspirin exacerbated respiratory diseases.
Kim HJ; Cho SH; Park JS; Lee TH; Lee EJ; Kim YH; Uh ST; Chung IY; Kim MK; Choi IS; Park BL; Shin HD; Park CS
J Hum Genet; 2012 Apr; 57(4):247-53. PubMed ID: 22377711
[TBL] [Abstract][Full Text] [Related]
37. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD.
Choi GS; Kim JH; Shin YS; Ye YM; Kim SH; Park HS
Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280
[TBL] [Abstract][Full Text] [Related]
38. Heat shock protein 70 gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease.
Kikuchi K; Abe S; Kodaira K; Yukawa T; Hozawa S; Mochizuki H; Kurosawa M
J Investig Med; 2013 Apr; 61(4):708-14. PubMed ID: 23392055
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.
Liu T; Laidlaw TM; Katz HR; Boyce JA
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16987-92. PubMed ID: 24085850
[TBL] [Abstract][Full Text] [Related]
40. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Choudhury A; Chung I; Blann AD; Lip GY
J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
